ctDNA Test for Resectable Pancreatic Cancer
ctDNA Assay in Patients With Resectable Pancreatic Cancer
Recruiting
Observational Study
Pancreas Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- University of Oklahoma · Other
Who this trial is looking for
This trial is looking for adults with recently diagnosed pancreatic cancer who may have the disease surgically removed. Participants will provide blood samples to help researchers understand cancer markers and patient survival.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with exocrine pancreatic cancer.
- I am at least 18 years old.
- I have a life expectancy of at least 6 months.
- I can give written consent and agree to HIPAA rules.
- I have a good performance status (ECOG 0 or 1).
- I am eligible for surgery or certain chemotherapy treatments.
You may not be able to join if
- I have a different type of pancreatic tumor, like neuroendocrine.
- I am pregnant, breastfeeding, or have a positive pregnancy test.
- I have serious heart problems that could affect my safety.
- I have locally advanced or metastatic cancer.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to determine the proportion of positive ctDNA -freely circulating tumor DNA fragments found in the blood plasma- in patients with pancreatic cancer and to better understand the relationship between possible ctDNA biomarkers and patient survival. A successful study may provide preliminary evidence that helps improve future patient care through targeted diagnostics, prog…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
1. Newly diagnosed exocrine pancreatic cancer with either pathology or radiology imaging suggestive of adenocarcinoma
2. Resectable/Borderline Resectable Pancreatic cancer as defined by the NCCN guidelines
3. ≥ 18 years old at the time of informed consent
4. ECOG Performance Stat…
Contacts